Catalent and Blackstone Complete Secondary Offering
06.14.16
This is only gets display when printing
Simpson Thacher represented Catalent, Inc. and Blackstone Healthcare Partners L.L.C., an affiliate of The Blackstone Group, L.P., in connection with a secondary offering of 10,000,000 shares of common stock at a public offering price of $24.85, resulting in gross proceeds of approximately $249 million to the selling stockholders. The offering closed on June 9, 2016.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.
The Simpson Thacher team included Ed Tolley, Xavier Kowalski, Kyle Scherer and Derek Stueben (Capital Markets); James Rapp and Joia Lee (Public Company Advisory Practice); and John Torrenti (Tax).